Bad Blood

£10.99

The shocking true story of the biggest corporate fraud since Enron, a gripping cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley.

Out of stock

Description

Now with a new afterword covering the months-long landmark trials of Elizabeth Holmes and Sunny Balwani.

‘I couldn’t put down this thriller . . . the perfect book to read by the fire this winter.’ Bill Gates

Winner of the Financial Times/McKinsey Business Book of the Year Award 2018

The riveting true story of the breathtaking rise and shocking collapse of Theranos, the multibillion-dollar biotech startup founded by Elizabeth Holmes, by the prize-winning journalist who first broke the story and pursued it to the end, despite pressure from its charismatic CEO and threats by her lawyers.

In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup ‘unicorn’ promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes’s worth at an estimated $4.7 billion. There was just one problem: the technology didn’t work.

In Bad Blood, John Carreyrou tells the riveting story of the biggest corporate fraud since Enron, a tale of ambition and hubris set amid the bold promises of Silicon Valley.

‘Chilling . . . Reads like a West Coast version of All the President’s Men.’ New York Times Book Review

Additional information

Weight 0.282 kg
Dimensions 19.7 × 13 × 2.7 cm
Author

Publisher

Imprint

Cover

Pages

Language

Edition

Dewey

Readership

Testimonials

Get 10% discount
on your first order!

Sign up for our newsletter and unlock a world of stories - plus get 10% off discount voucher to use on your first order.You'll be the first to hear about exciting new releases, upcoming author events, exclusive offers, and much more.